{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:08:34Z","timestamp":1791263314800,"version":"4.1.0"},"reference-count":274,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bcp.2012.01.002","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T19:54:57Z","timestamp":1326311697000},"page":"1084-1103","source":"Crossref","is-referenced-by-count":355,"title":["Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance"],"prefix":"10.1016","volume":"83","author":[{"given":"Karthika","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas D.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.01.002_bib0005","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-60761-416-6_12","article-title":"Impact of breast cancer resistance protein on cancer treatment outcomes","author":"Ross","year":"2010"},{"key":"10.1016\/j.bcp.2012.01.002_bib0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12033-009-9220-6","article-title":"Pharmacogenetics of membrane transporters: an update on current approaches","volume":"44","author":"Sissung","year":"2010","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1208\/s12248-009-9132-1","article-title":"Structure-activity relationships and quantitative structure-activity relationships for breast cancer resistance protein (ABCG2)","volume":"11","author":"Gandhi","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.bcp.2012.01.002_bib0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jps.21851","article-title":"Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response","volume":"99","author":"Alvarez","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","article-title":"ABCG2: a perspective","volume":"61","author":"Robey","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bcp.2012.01.002_bib0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/138920111795163913","article-title":"The challenge of exploiting ABCG2 in the clinic","volume":"12","author":"Robey","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2010.11.007","article-title":"Emerging role for drug transporters at the blood\u2013testis barrier","volume":"32","author":"Mruk","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-642-14541-4_9","article-title":"In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP\/MXR\/ABCP\/ABCG2)","volume":"201","author":"Schwabedissen","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0045","article-title":"Breast cancer resistance protein (BCRP\/ABCG2): its role in multidrug resistance and regulation of its gene expression","author":"Nakanishi","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0050","first-page":"48","article-title":"Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients","volume":"10","author":"Ross","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0055","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1016\/S0021-9258(19)38781-2","article-title":"Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein","volume":"265","author":"Chen","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0060","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2012.01.002_bib0065","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0070","first-page":"8","article-title":"Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes","volume":"59","author":"Miyake","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.10100","article-title":"Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization","volume":"97","author":"Kage","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0080","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1124\/mol.64.6.1452","article-title":"Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis","volume":"64","author":"Nakanishi","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0085","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"Xu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0090","doi-asserted-by":"crossref","first-page":"36926","DOI":"10.1074\/jbc.M502937200","article-title":"Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2","volume":"280","author":"Henriksen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0095","doi-asserted-by":"crossref","first-page":"27841","DOI":"10.1074\/jbc.C700133200","article-title":"Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein","volume":"282","author":"Wakabayashi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0100","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.str.2006.08.014","article-title":"Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2","volume":"14","author":"McDevitt","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2012.01.002_bib0105","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1021\/bi0479858","article-title":"N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane","volume":"44","author":"Diop","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2012.01.002_bib0110","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1111\/j.1742-4658.2009.07423.x","article-title":"Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2","volume":"276","author":"Nakagawa","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2012.01.002_bib0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.addr.2008.08.008","article-title":"Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation","volume":"61","author":"Wakabayashi-Nakao","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bcp.2012.01.002_bib0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2011.07.001","article-title":"The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system","volume":"64","author":"Moreno-Sanz","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0125","doi-asserted-by":"crossref","first-page":"e19164","DOI":"10.1371\/journal.pone.0019164","article-title":"Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro","volume":"6","author":"Balabanov","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib0130","first-page":"47","article-title":"Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein","volume":"60","author":"Rabindran","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0135","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0140","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/mp2000132","article-title":"Poloxamines display a multiple inhibitory activity of ATP-Binding Cassette (ABC) transporters in cancer cell lines","volume":"8","author":"Cuestas","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bcp.2012.01.002_bib0145","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1158\/1535-7163.MCT-10-0874","article-title":"Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP\/ABCG2-mediated drug resistance in vitro and in vivo","volume":"10","author":"Yamazaki","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0150","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1158\/0008-5472.CAN-03-3344","article-title":"Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro","volume":"64","author":"Houghton","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0155","doi-asserted-by":"crossref","first-page":"e19329","DOI":"10.1371\/journal.pone.0019329","article-title":"The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1\/P-Glycoprotein Transporter","volume":"6","author":"Ding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib0160","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"Burger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1593\/neo.81264","article-title":"Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2\/BCRP and ABCB1\/Pgp","volume":"11","author":"Zhang","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0170","doi-asserted-by":"crossref","first-page":"L97","DOI":"10.1152\/ajplung.00009.2003","article-title":"Side population cells and Bcrp1 expression in lung","volume":"285","author":"Summer","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0175","first-page":"368","article-title":"Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells","volume":"88","author":"Wulf","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2012.01.002_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-385493-3.00002-4","article-title":"Detection of hematopoietic stem cells by flow cytometry","volume":"103","author":"Lin","year":"2011","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0185","doi-asserted-by":"crossref","unstructured":"Fatima S, Zhou S, Sorrentino BP. Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model. Stem Cells 2011, Dec 1 [Epub ahead of print] PubMed PMID: 22134889.","DOI":"10.1002\/stem.1002"},{"key":"10.1016\/j.bcp.2012.01.002_bib0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V99.2.507","article-title":"The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0195","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1517\/17425250903228834","article-title":"ABCG2: the key to chemoresistance in cancer stem cells","volume":"5","author":"An","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0200","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ijc.24796","article-title":"Suppression of ABCG2 inhibits cancer cell proliferation","volume":"126","author":"Chen","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0205","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0210","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","article-title":"Localisation of breast cancer resistance protein in microvessel endothelium of human brain","volume":"13","author":"Cooray","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.bcp.2012.01.002_bib0215","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.ejca.2004.05.010","article-title":"The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours","volume":"40","author":"Bart","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0220","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1248\/bpb.27.753","article-title":"Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood-placenta barrier","volume":"27","author":"Kitano","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bcp.2012.01.002_bib0225","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s11095-006-0067-2","article-title":"ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells","volume":"23","author":"Asashima","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10637-008-9138-z","article-title":"The effect of P-gp (Mdr1a\/1b), BCRP (Bcrp1) and P-gp\/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib","volume":"27","author":"Oostendorp","year":"2009","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2012.01.002_bib0235","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2012.01.002_bib0240","doi-asserted-by":"crossref","first-page":"24218","DOI":"10.1074\/jbc.M313599200","article-title":"The stem cell marker Bcrp\/ABCG2 enhances hypoxic cell survival through interactions with heme","volume":"279","author":"Krishnamurthy","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0245","doi-asserted-by":"crossref","first-page":"e4023","DOI":"10.1371\/journal.pone.0004023","article-title":"Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells","volume":"3","author":"Susanto","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib0250","doi-asserted-by":"crossref","unstructured":"Desuzinges-Mandon E, Arnaud O, Martinez L, Huche F, Di Pietro A, Falson P. ABCG2 transports and transfers heme to albumin through its large extracellular loop. J Biol Chem 285:33123\u201333133.","DOI":"10.1074\/jbc.M110.139170"},{"key":"10.1016\/j.bcp.2012.01.002_bib0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pharmthera.2007.02.001","article-title":"The role of transporters in cellular heme and porphyrin homeostasis","volume":"114","author":"Krishnamurthy","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0260","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1158\/0008-5472.CAN-08-4315","article-title":"Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines","volume":"69","author":"Solazzo","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0265","first-page":"4048","article-title":"Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-d-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0270","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1535-7163.MCT-08-0768","article-title":"Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins","volume":"8","author":"Lemos","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0275","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ijc.23677","article-title":"Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells","volume":"123","author":"Lemos","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0280","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0285","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2012.01.002_bib0290","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"Dehghan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2012.01.002_bib0295","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1158\/0008-5472.CAN-05-4572","article-title":"Novel 5\u2019 untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage","volume":"66","author":"Nakanishi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0300","doi-asserted-by":"crossref","first-page":"29625","DOI":"10.1074\/jbc.M606314200","article-title":"Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters","volume":"281","author":"Zong","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbagrm.2011.06.004","article-title":"Identification and characterization of the major alternative promoter regulating Bcrp1\/Abcg2 expression in the mouse intestine","volume":"1809","author":"Natarajan","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2012.01.002_bib0310","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.leukres.2011.05.004","article-title":"Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia","volume":"35","author":"Campbell","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0315","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0167-4781(01)00270-6","article-title":"Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene","volume":"1520","author":"Bailey-Dell","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2012.01.002_bib0320","doi-asserted-by":"crossref","first-page":"24218","DOI":"10.1074\/jbc.M313599200","article-title":"The stem cell marker Bcrp\/ABCG2 enhances hypoxic cell survival through interactions with heme","volume":"279","author":"Krishnamurthy","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0325","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/0008-5472.CAN-03-3583","article-title":"Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene","volume":"64","author":"Ee","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0330","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/labinvest.2008.157","article-title":"Synergistic effect of interleukin-6 and endoplasmic reticulum stress inducers on the high level of ABCG2 expression in plasma cells","volume":"89","author":"Nakamichi","year":"2009","journal-title":"Lab Invest"},{"key":"10.1016\/j.bcp.2012.01.002_bib0335","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/mol.107.044289","article-title":"Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression","volume":"73","author":"Vore","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0340","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/mol.107.041087","article-title":"Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells","volume":"73","author":"Wang","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib69","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/onc.2011.195","article-title":"ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma","volume":"48","author":"Singh","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2012.01.002_bib0350","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1158\/1535-7163.MCT-10-0108","article-title":"Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype","volume":"9","author":"Singh","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0355","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1541-7786.MCR-10-0270","article-title":"Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathway","volume":"9","author":"To","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0360","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.bcp.2010.08.016","article-title":"A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP\/ABCG2 in LS174T cells","volume":"80","author":"Tompkins","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0365","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/onc.2010.546","article-title":"Transforming growth factor-\u03b2 decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells","volume":"30","author":"Ehata","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2012.01.002_bib0370","doi-asserted-by":"crossref","first-page":"31100","DOI":"10.1074\/jbc.M110.155309","article-title":"Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements","volume":"285","author":"Pradhan","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0375","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jcp.22781","article-title":"The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2","volume":"227","author":"Hamada","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0380","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.febslet.2010.06.033","article-title":"Transcriptional suppression of breast cancer resistance protein (BCRP) by wild-type p53 through the NF-kappaB pathway in MCF-7 cells","volume":"584","author":"Wang","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2012.01.002_bib0385","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.110.167601","article-title":"Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux","volume":"334","author":"Agarwal","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0390","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCRESAHA.107.161729","article-title":"Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells","volume":"102","author":"Martin","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0395","doi-asserted-by":"crossref","first-page":"23812","DOI":"10.1074\/jbc.M604890200","article-title":"Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells","volume":"281","author":"Szatmari","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbrc.2008.07.149","article-title":"Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells","volume":"375","author":"Honorat","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2012.01.002_bib0405","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1021\/mp800116f","article-title":"C-myc amplification altered the gene expression of ABC- and SLC-transporters in human breast epithelial cells","volume":"6","author":"Kang","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bcp.2012.01.002_bib0410","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/toxsci\/kfn058","article-title":"X receptor protects HepG2 cells from BaP-induced DNA damage","volume":"104","author":"Naspinski","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib0415","doi-asserted-by":"crossref","first-page":"e18372","DOI":"10.1371\/journal.pone.0018372","article-title":"SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes","volume":"6","author":"Jeong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib0420","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-10-0510","article-title":"c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells","volume":"9","author":"Porro","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0425","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.3748\/wjg.v10.i23.3433","article-title":"Methylation profile of the promoter CpG islands of 14 drug-resistance genes in hepatocellular carcinoma","volume":"10","author":"Ding","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0430","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 expression, function, and promoter methylation in human multiple myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0435","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1128\/MCB.00650-06","article-title":"Aberrant promoter methylation of the ABCG2 gene in renal carcinoma","volume":"26","author":"To","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0440","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1541-7786.MCR-07-0175","article-title":"Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells","volume":"6","author":"To","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0445","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/sj.bjc.6604334","article-title":"Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes","volume":"98","author":"Calcagno","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0450","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/MCB.00331-08","article-title":"Regulation of ABCG2 expression at the 3\u2019 untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line","volume":"28","author":"To","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0455","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1158\/1535-7163.MCT-09-0292","article-title":"Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2","volume":"8","author":"To","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0460","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjc.6605724","article-title":"hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations","volume":"103","author":"Wang","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0465","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1124\/mol.108.054163","article-title":"MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP\/ABCG2) in human cancer cells","volume":"75","author":"Pan","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0470","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bcp.2010.12.018","article-title":"Breast cancer resistance protein BCRP\/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells","volume":"81","author":"Li","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0475","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1074\/jbc.M707773200","article-title":"The 44-kDa Pim-1 kinase phosphorylates BCRP\/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells","volume":"283","author":"Xie","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0480","doi-asserted-by":"crossref","first-page":"39068","DOI":"10.1074\/jbc.M306362200","article-title":"Akt signaling regulates side population cell phenotype via Bcrp1 translocation","volume":"278","author":"Mogi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0485","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/dmd.104.003228","article-title":"Regulation of the cell surface expression of human BCRP\/ABCG2 by the phosphorylation state of Akt in polarized cells","volume":"33","author":"Takada","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0490","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/abbs\/gmr050","article-title":"Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K\/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells","volume":"43","author":"Zhang","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.bcp.2012.01.002_bib0495","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-60761-416-6_6","article-title":"Pharmacogenetics of ATP-binding cassette transporters and clinical implications","volume":"596","author":"Cascorbi","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0500","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1042\/BJ20071229","article-title":"Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2","volume":"411","author":"Nakagawa","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2012.01.002_bib0505","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2217\/14622416.9.8.1005","article-title":"Pharmacogenomic importance of ABCG2","volume":"9","author":"Cusatis","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bcp.2012.01.002_bib0510","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/17425255.4.7.923","article-title":"Intestinal efflux transporters and drug absorption","volume":"4","author":"Murakami","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0515","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1158\/1078-0432.CCR-08-2940","article-title":"Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo","volume":"15","author":"Vlaming","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0520","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/1535-7163.MCT-09-0668","article-title":"Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo","volume":"8","author":"Vlaming","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0525","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/187231210792928279","article-title":"P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor","volume":"4","author":"Yang","year":"2010","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.bcp.2012.01.002_bib0530","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s11095-008-9678-0","article-title":"Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells","volume":"25","author":"Li","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0535","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/1535-7163.MCT-07-2250","article-title":"Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1\u2212\/\u2212\/Mdr1a\/1b\u2212\/\u2212 (triple-knockout) and wild-type mice","volume":"7","author":"Marchetti","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0540","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1158\/0008-5472.CAN-03-4062","article-title":"Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions","volume":"64","author":"Breedveld","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0545","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s002800050949","article-title":"Omeprazole does not alter plasma methotrexate clearance","volume":"44","author":"Whelan","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0550","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2005.02513.x","article-title":"Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients","volume":"62","author":"Joerger","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0555","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2125.2008.03303.x","article-title":"Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy","volume":"67","author":"Suzuki","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0560","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2009.04.002","article-title":"Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1\/Pgp and ABCG2\/BCRP\/MXR transporters","volume":"78","author":"Tiwari","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0565","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-7843.2008.00298.x","article-title":"Antipsychotic drugs inhibit the function of breast cancer resistance protein","volume":"103","author":"Wang","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0570","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1158\/0008-5472.CAN-10-3820","article-title":"Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance","volume":"71","author":"Shi","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0575","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1158\/0008-5472.CAN-05-2915","article-title":"Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo","volume":"66","author":"Leggas","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0580","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1158\/0008-5472.CAN-04-0096","article-title":"Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice","volume":"64","author":"Stewart","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0585","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00280-009-1039-0","article-title":"Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences","volume":"65","author":"Azzariti","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0590","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1349-7006.2009.01213.x","article-title":"Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib","volume":"100","author":"Noguchi","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib0595","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","article-title":"Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters","volume":"70","author":"Mi","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0600","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/dmd.108.024612","article-title":"Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2","volume":"37","author":"Shukla","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0605","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/156802609787521580","article-title":"Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2)","volume":"9","author":"Nicolazzo","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib0610","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1158\/1078-0432.CCR-07-1335","article-title":"P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan","volume":"13","author":"de Vries","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0615","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/mp1003898","article-title":"Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood\u2013brain barrier","volume":"8","author":"Poller","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bcp.2012.01.002_bib0620","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1535-7163.MCT-09-0663","article-title":"Breast cancer resistance protein and P-glycoprotein limit sorafenib brain accumulation","volume":"9","author":"Lagas","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0625","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.110.175034","article-title":"The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain","volume":"336","author":"Agarwal","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0630","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1078-0432.CCR-10-1934","article-title":"Role of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation","volume":"17","author":"Elmeliegy","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib127","first-page":"31","article-title":"Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP","volume":"27","author":"de Vries","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2012.01.002_bib0640","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1158\/0008-5472.CAN-09-0700","article-title":"Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid","volume":"69","author":"Shen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0645","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/dmd.108.024646","volume":"37","author":"Polli","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0650","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/dmd.108.024489","article-title":"The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice","volume":"37","author":"Zhou","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0655","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1124\/dmd.110.034256","article-title":"Role of P-glycoprotein and breast cancer resistance protein-1 in the brain penetration and brain pharmacodynamic activity of the novel phosphatidylinositol 3-kinase inhibitor GDC-0941","volume":"38","author":"Salphati","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0660","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.109.154781","article-title":"P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib","volume":"330","author":"Chen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0665","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/dmd.110.037317","article-title":"Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics","volume":"39","author":"Poller","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0670","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.109.162321","article-title":"Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone","volume":"333","author":"Kodaira","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0675","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1124\/dmd.108.025064","article-title":"Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood\u2013brain barrier","volume":"37","author":"Zhao","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0680","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10571-009-9431-1","article-title":"Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier","volume":"30","author":"Poller","year":"2010","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0685","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00011-009-0034-6","article-title":"Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7\/MX","volume":"58","author":"Mosaffa","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0690","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/ars.2008.2095","article-title":"Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities","volume":"11","author":"Kuo","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bcp.2012.01.002_bib0695","first-page":"333","article-title":"ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells","volume":"25","author":"Sakata","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2012.01.002_bib0700","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ijc.26000","article-title":"Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration","volume":"130","author":"Tang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0705","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/mp1001729","article-title":"BCRP at the blood\u2013brain barrier: genomic regulation by 17beta-estradiol","volume":"7","author":"Mahringer","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bcp.2012.01.002_bib0710","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.leu.2403395","article-title":"Breast cancer resistance protein (BCRP\/MXR\/ABCG2) in acute myeloid leukemia: discordance between expression and function","volume":"18","author":"Suvannasankha","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0715","first-page":"3320","article-title":"Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients","volume":"9","author":"Nakanishi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0720","first-page":"5171","article-title":"The role of breast cancer resistance protein in acute lymphoblastic leukemia","volume":"9","author":"Plasschaert","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0725","first-page":"6635","article-title":"Acquired mutations in the MXR\/BCRP\/ABCP gene alter substrate specificity in MXR\/BCRP\/ABCP-overexpressing cells","volume":"61","author":"Honjo","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.leu.2403168","article-title":"Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein","volume":"18","author":"Stam","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0735","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/sj.leu.2402541","article-title":"BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia","volume":"16","author":"Steinbach","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0740","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1158\/1078-0432.CCR-04-0795","article-title":"Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias","volume":"10","author":"Benderra","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0745","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1158\/1078-0432.CCR-04-1895","article-title":"MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia","volume":"11","author":"Benderra","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0750","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.leukres.2004.06.004","article-title":"BCRP mRNA expression v. clinical outcome in 40 adult AML patients","volume":"29","author":"Uggla","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0755","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1182\/blood-2002-01-0271","article-title":"Low levels of ABCG2 expression in adult AML blast samples","volume":"100","author":"Abbott","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0760","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1182\/blood.V99.10.3763","article-title":"Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia","volume":"99","author":"van der Kolk","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0765","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1078-0432.CCR-04-0212","article-title":"Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia","volume":"11","author":"Raaijmakers","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0770","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cyto.b.20403","article-title":"Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia","volume":"74","author":"de Figueiredo-Pontes","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.bcp.2012.01.002_bib0775","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood-2006-02-001594","article-title":"SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice","volume":"108","author":"Ma","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0780","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2011-01-333641","article-title":"SALL4 is a robust stimulator for the expansion of hematopoietic stem cells","volume":"118","author":"Aguila","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0785","first-page":"825","article-title":"The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype","volume":"91","author":"Damiani","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2012.01.002_bib0790","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.leukres.2003.09.002","article-title":"Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients","volume":"28","author":"Galimberti","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0795","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.exphem.2007.11.014","article-title":"MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia","volume":"36","author":"Ho","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0800","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00277-007-0269-7","article-title":"CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age","volume":"86","author":"van den Heuvel-Eibrink","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0805","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/cncr.25753","article-title":"Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse","volume":"117","author":"Tiribelli","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0810","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1158\/1535-7163.MCT-08-0427","article-title":"Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides","volume":"7","author":"de Wolf","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0815","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.leukres.2010.01.008","article-title":"Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients","volume":"34","author":"Damiani","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0820","first-page":"145","article-title":"Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr\/BCrp\/ABCP1), in flavopiridol-resistant human breast cancer cells","volume":"7","author":"Robey","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0825","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/leu.2008.87","article-title":"Amonafide l-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia","volume":"22","author":"Burcu","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0830","doi-asserted-by":"crossref","unstructured":"Stone RM, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, et al. A phase III, open label, randomized comparison of AS1413 (amonafide l-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE). J Clin Oncol 2011;29:(suppl; abstr 6520).","DOI":"10.1200\/jco.2011.29.15_suppl.6520"},{"key":"10.1016\/j.bcp.2012.01.002_bib0835","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin A is a broad-spectrum multidrug resistance modulator","volume":"11","author":"Qadir","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0840","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood.V98.12.3212","article-title":"Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study","volume":"98","author":"List","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0845","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00001813-200603000-00001","article-title":"Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP\/ABCG2)","volume":"17","author":"Ahmed-Belkacem","year":"2006","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2012.01.002_bib0850","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/0008-5472.CAN-03-3298","article-title":"Pheophorbide a is a specific probe for ABCG2 function and inhibition","volume":"64","author":"Robey","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0855","first-page":"427","article-title":"Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP\/ABCG2)","volume":"1","author":"Allen","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.01.002_bib0860","first-page":"935","article-title":"Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918","volume":"7","author":"Maliepaard","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0865","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1158\/1078-0432.CCR-08-2048","article-title":"Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes","volume":"15","author":"Hauswald","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0870","first-page":"201","article-title":"Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with acute myeloid leukemia","volume":"1","author":"Hampras","year":"2010","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.bcp.2012.01.002_bib0875","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/dmd.107.018366","article-title":"Association of breast cancer resistance protein\/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms","volume":"36","author":"Poonkuzhali","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0880","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ejca.2011.03.032","article-title":"Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia","volume":"47","author":"Wang","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0885","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.2002.03550.x","article-title":"Expression of the BCRP gene (ABCG2\/MXR\/ABCP) in childhood acute lymphoblastic leukaemia","volume":"118","author":"Sauerbrey","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0890","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.2004.05211.x","article-title":"Breast cancer resistance protein (BCRP\/MXR\/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival","volume":"127","author":"Suvannasankha","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0895","first-page":"5035","article-title":"Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance","volume":"62","author":"Volk","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0900","first-page":"5538","article-title":"Wild-type breast cancer resistance protein (BCRP\/ABCG2) is a methotrexate polyglutamate transporter","volume":"63","author":"Volk","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0905","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1532\/IJH97.E0624","article-title":"Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia","volume":"86","author":"Kourti","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0910","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/pbc.22220","article-title":"mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death","volume":"53","author":"Cortez","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib0915","first-page":"248","article-title":"Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy","volume":"30","author":"Fedasenka","year":"2008","journal-title":"Exp Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0920","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.leukres.2007.12.009","article-title":"Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia","volume":"32","author":"Semsei","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0925","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0930","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2006-02-003145","article-title":"Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate","volume":"108","author":"Jordanides","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0935","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0940","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/leu.2011.65","article-title":"Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia","volume":"25","author":"Lu","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0945","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.65.6.1485","article-title":"High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter","volume":"65","author":"Ozvegy-Laczka","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0950","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2005-10-4020","article-title":"Complex interaction of BCRP\/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression","volume":"108","author":"Nakanishi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib0955","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/0008-5472.CAN-04-2416","volume":"65","author":"Breedveld","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0960","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.leu.2404638","article-title":"Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells","volume":"21","author":"Brendel","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2012.01.002_bib0965","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-07-5095","article-title":"Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications","volume":"14","author":"Hiwase","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0970","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1124\/dmd.109.031302","article-title":"Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib","volume":"38","author":"Dohse","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.01.002_bib0975","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1476-5381.2009.00383.x","article-title":"Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties","volume":"158","author":"Hegedus","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib0980","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000324900","article-title":"Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase","volume":"87","author":"Takahashi","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2012.01.002_bib0985","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1158\/1078-0432.CCR-09-0145","article-title":"Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia","volume":"15","author":"Kim","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0990","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.leukres.2005.04.013","article-title":"Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma","volume":"29","author":"Raaijmakers","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib0995","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1182\/blood-2010-02-267344","article-title":"Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications","volume":"117","author":"Jakubikova","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2012.01.002_bib1000","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-0463.2008.00974.x","article-title":"Immunohistochemical expression of multidrug resistance proteins in mature T\/NK-cell lymphomas","volume":"116","author":"Saglam","year":"2008","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.bcp.2012.01.002_bib1005","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1349-7006.2008.00985.x","article-title":"ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide\/doxorubicin\/vincristine\/prednisone chemotherapy","volume":"99","author":"Kim","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib1010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjc.6605553","article-title":"Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling","volume":"102","author":"Nakanishi","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1015","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/stem.192","article-title":"Lack of ABCG2 expression and side population properties in human pluripotent stem cells","volume":"27","author":"Zeng","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcp.2012.01.002_bib1020","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1349-7006.2009.01288.x","article-title":"Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2\/BCRP-mediated drug export","volume":"100","author":"Katayama","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib1025","first-page":"1055","article-title":"Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma","volume":"124","author":"Yang","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bcp.2012.01.002_bib1030","first-page":"273","article-title":"Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1","volume":"35","author":"Yajima","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archotol.134.9.979","article-title":"Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma","volume":"134","author":"Chu","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bcp.2012.01.002_bib1040","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.bjc.6605668","article-title":"Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer","volume":"102","author":"Salcido","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5732\/cjc.009.10330","article-title":"Biologic characteristics of the side population of human small cell lung cancer cell line H446","volume":"29","author":"Wang","year":"2010","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1050","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0905653106","article-title":"Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment","volume":"106","author":"Bertolini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2012.01.002_bib1055","doi-asserted-by":"crossref","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","article-title":"Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib1060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2008.04.038","article-title":"Characterization of a stem cell population in lung cancer A549 cells","volume":"371","author":"Sung","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2012.01.002_bib1065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPA.0b013e3181c31314","article-title":"Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells","volume":"39","author":"Hong","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.bcp.2012.01.002_bib1070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4149\/neo_2009_05_371","article-title":"A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics","volume":"56","author":"Wang","year":"2009","journal-title":"Neoplasma"},{"key":"10.1016\/j.bcp.2012.01.002_bib1075","first-page":"2041","article-title":"Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells","volume":"30","author":"Chikazawa","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1080","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6605610","article-title":"Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery","volume":"102","author":"Fang","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23692","article-title":"Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway","volume":"52","author":"Wang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2012.01.002_bib1090","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/carcin\/bgn223","article-title":"Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling","volume":"29","author":"Hu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.01.002_bib1095","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00432-008-0407-1","article-title":"Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials","volume":"134","author":"Shi","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1100","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","article-title":"Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant","volume":"102","author":"Hu","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3171\/JNS\/2008\/109\/11\/0856","article-title":"Characterization of a side population of astrocytoma cells in response to temozolomide","volume":"109","author":"Chua","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bcp.2012.01.002_bib1110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/0883073808321771","article-title":"Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas","volume":"23","author":"Maria","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1115","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-09-0143","article-title":"Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides","volume":"69","author":"Slomiany","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1120","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1158\/0008-5472.CAN-09-3463","article-title":"CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance","volume":"70","author":"Adhikari","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jcp.21667","article-title":"Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment","volume":"219","author":"Di Fiore","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11010-010-0426-5","article-title":"Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1","volume":"340","author":"Liu","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2012.01.002_bib1135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbrc.2009.12.020","article-title":"Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro","volume":"391","author":"Yang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2012.01.002_bib1140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0714.2009.00807.x","article-title":"Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors","volume":"39","author":"Kumamoto","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.bcp.2012.01.002_bib1145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/147323000903700304","article-title":"Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24","volume":"37","author":"Ning","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1150","doi-asserted-by":"crossref","first-page":"e4235","DOI":"10.1371\/journal.pone.0004235","article-title":"Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus","volume":"4","author":"Mahller","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib1155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hed.20935","article-title":"In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line","volume":"31","author":"Wei","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.bcp.2012.01.002_bib1160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1309\/BTLN5WTMJ3PCNRRC","article-title":"Expression of protein tyrosine kinases in head and neck squamous cell carcinomas","volume":"124","author":"Ongkeko","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1165","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1091\/mbc.e02-11-0704","article-title":"Subcellular localization and activity of multidrug resistance proteins","volume":"14","author":"Rajagopal","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2012.01.002_bib1170","doi-asserted-by":"crossref","first-page":"e16007","DOI":"10.1371\/journal.pone.0016007","article-title":"Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance","volume":"6","author":"Goler-Baron","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2012.01.002_bib1175","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1158\/0008-5472.CAN-05-2021","article-title":"Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance","volume":"65","author":"Ifergan","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2008.12.168","article-title":"Riboflavin concentration within ABCG2-rich extracellular vesicles is a novel marker for multidrug resistance in malignant cells","volume":"380","author":"Ifergan","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2012.01.002_bib1185","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/CAD.0b013e32833179bf","article-title":"Role of efflux pump activity in lapatinib\/caelyx combination in breast cancer cell lines","volume":"20","author":"Vannini","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2012.01.002_bib1190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2009.08.021","article-title":"Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance","volume":"79","author":"Kuang","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1195","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1158\/0008-5472.CAN-08-0499","article-title":"Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2","volume":"68","author":"Dai","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0895-3988(08)60044-6","article-title":"Breast cancer resistance protein expression and 5-fluorouracil resistance","volume":"21","author":"Yuan","year":"2008","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib1205","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-008-0838-z","article-title":"Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer","volume":"63","author":"Yuan","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000143400","article-title":"Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer","volume":"29","author":"Vannini","year":"2008","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1215","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1200\/JCO.2009.25.7246","article-title":"Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients","volume":"28","author":"Kiyotani","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1220","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.lfs.2008.07.017","article-title":"Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line","volume":"83","author":"Liu","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2012.01.002_bib1225","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-09-3367","article-title":"Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan","volume":"70","author":"Zander","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1230","first-page":"705","article-title":"Expression of Breast Cancer Resistance Protein (BCRP-1) in canine mammary adenocarcinomas and adenomas","volume":"23","author":"Nowak","year":"2009","journal-title":"In Vivo"},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2012.01.002_bib1235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1439-0531.2009.01382.x","article-title":"Expression of ABC-transport proteins in canine mammary cancer: consequences for chemotherapy","volume":"44","author":"Honscha","year":"2009","journal-title":"Reprod Domest Anim"},{"key":"10.1016\/j.bcp.2012.01.002_bib1240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2008.10.008","article-title":"Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer","volume":"65","author":"Kim","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2008.07.014","article-title":"Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy","volume":"64","author":"Ota","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1250","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.tiv.2008.09.001","article-title":"Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP","volume":"22","author":"Ceckova","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bcp.2012.01.002_bib1255","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.23956","article-title":"Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients","volume":"124","author":"Muller","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.lungcan.2007.05.019","article-title":"Breast cancer resistance protein (BCRP) affected acquired resistance to gefitinib in a never-smoked female patient with advanced non-small cell lung cancer","volume":"58","author":"Usuda","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1265","doi-asserted-by":"crossref","first-page":"20558","DOI":"10.1074\/jbc.M111.240796","article-title":"Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib1270","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/JTO.0b013e3181f0b6af","article-title":"Downregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancer","volume":"5","author":"Ohtsuka","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1275","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3816\/CLC.2009.n.078","article-title":"Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival","volume":"10","author":"Li","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1280","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lungcan.2009.09.013","article-title":"Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy","volume":"69","author":"Li","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1285","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1158\/1078-0432.CCR-0937-3","article-title":"Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer","volume":"10","author":"Yoh","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2009.04.002","article-title":"Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer","volume":"67","author":"Usuda","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1295","doi-asserted-by":"crossref","first-page":"814140","DOI":"10.1155\/2009\/814140","article-title":"Response of patient-derived non-small cell lung cancer xenografts to classical and targeted therapies is not related to multidrug resistance markers","volume":"2009","author":"Rolff","year":"2009","journal-title":"J Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1300","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cncr.25510","article-title":"Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome","volume":"117","author":"Tanaka","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2012.01.002_bib1310","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.bcp.2009.07.006","article-title":"Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy","volume":"78","author":"Theile","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.01.002_bib262","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/jac\/dkq324","article-title":"Impact of drug transporters on cellular resistance towards saquinavir and darunavir","volume":"65","author":"Konig","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bcp.2012.01.002_bib1320","first-page":"159","article-title":"Biochemical rationale for the synergism of 5-fluorouracil and folinic acid","volume":"5","author":"Moran","year":"1987","journal-title":"NCI Monogr"},{"key":"10.1016\/j.bcp.2012.01.002_bib1325","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1872-034X.2008.00381.x","article-title":"Up-regulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: a study in patients and in vitro","volume":"38","author":"Vander Borght","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1330","doi-asserted-by":"crossref","first-page":"26273","DOI":"10.1074\/jbc.M109.028068","article-title":"Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library","volume":"284","author":"Zhao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.01.002_bib1335","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/scd.2008.0033","article-title":"Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines","volume":"18","author":"Huang","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bcp.2012.01.002_bib1340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2012.01.002_bib1345","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00432-009-0578-4","article-title":"ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma","volume":"135","author":"Jin","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1350","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.4161\/cc.8.18.9504","article-title":"The ABCG2 resistance network of glioblastoma","volume":"8","author":"Bleau","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2012.01.002_bib1355","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1541-7786.MCR-06-0184","article-title":"Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix","volume":"4","author":"Lee","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2012.01.002_bib1360","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/onc.2009.103","article-title":"Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters","volume":"28","author":"Martin","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2012.01.002_bib1365","doi-asserted-by":"crossref","first-page":"C440","DOI":"10.1152\/ajpcell.00491.2007","article-title":"Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier","volume":"295","author":"Narang","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1370","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1750-3639.2010.00389.x","article-title":"P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) localize in the microvessels forming the blood\u2013tumor barrier in ependymomas","volume":"20","author":"Ginguene","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.bcp.2012.01.002_bib1375","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2008.10.038","article-title":"Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins","volume":"601","author":"Colabufo","year":"2008","journal-title":"Eur J Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T15:47:21Z","timestamp":1713368841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":274,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0006295212000275"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.01.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}